View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
  • Protocol ID
    ACNS1422
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Perth Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 2
  • Study type
    Treatment
  • Diagnosis stage
    New diagnosis
  • Study open date
    02/10/2017
  • Study close date
    N/A
  • Study chair
    Nicholas Gottardo, MBChB
  • Sponsor
    Children's Oncology Group
Back to search results